| SPECIAL ARTICLE |
|
| Year : 2022 | Volume
: 5
| Issue : 1 | Page : 4-8 |
|
|
Anaesthetic considerations in rhino-orbito-cerebral mucormycosis
Hemlata Kapoor1, Mohan Kumar Terdal1, Sanjiv Badhwar2, Faizan Rahmani2
1 Department of Anaesthesiology, Kokilaben Dhirubhai Ambani Hospital and Research Centre, Mumbai, Maharashtra, India
2 Department of ENT, Kokilaben Dhirubhai Ambani Hospital and Research Centre, Mumbai, Maharashtra, India
Correspondence Address:
Dr. Hemlata Kapoor
Department of Anaesthesiology, Kokilaben Dhirubhai Ambani Hospital and Research Institute, Four Bungalows, Mumbai - 400 053, Maharashtra
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/arwy.arwy_56_21
|
|
|
Rhino-orbito-cerebral mucormycosis is a serious infection that can complicate the course of coronavirus disease 2019 (COVID-19). Surgical debridement of infected/necrotic tissue along with antifungal co-medication constitutes the mainstay of treatment. Amphotericin B can produce electrolyte imbalance and nephrotoxicity. The lungs and other organs can be affected to various extents by COVID-19 infection. Both mask ventilation and intubation can be difficult in these patients. Meticulous preoperative evaluation and optimisation, followed by a carefully planned anaesthetic aimed at maintaining haemodynamic stability, often spells success. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
